Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.090
-0.020 (-0.64%)
Aug 31, 2026, 10:45 AM EDT - Market open
Altimmune Market Cap
Altimmune has a market cap or net worth of $601.06 million as of August 31, 2026. Its market cap has increased by 77.82% in one year.
Market Cap
601.06M
Enterprise Value
310.80M
1-Year Change
77.82%
Ranking
Category
Stock Price
$3.09
ChartMarket Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $601.06M, a decrease of -72.57%. That is a compound annual growth rate of -12.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 601.06M | 52.53% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 648.60M |
| CorMedix | 646.94M |
| Prime Medicine | 642.23M |
| Contineum Therapeutics | 641.44M |
| REGENXBIO | 637.69M |
| Autolus Therapeutics | 622.82M |
| Valneva SE | 615.36M |
| Arvinas | 600.25M |